CVR: 41590939
BioClinica ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported a gross profit of DKK -63,754 and a net result of DKK -73,479 compared with DKK -24,530 the year before. Equity amounted to DKK -168,480.
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationScreen owners and management against the Danish FSA's official PEP lists
BioClinica ApS was dissolved on March 10, 2026.
As of February 26, 2026, Niels Løber has stepped down as liquidator of BioClinica ApS.
On February 26, 2026, BioClinica ApS exited liquidation.
BioClinica ApS has published its annual report for 2024. Gross profit came to DKK -63,754, and the net result was DKK -73,479.
As of May 12, 2025, Niels Løber is registered as liquidator of BioClinica ApS.
As of May 12, 2025, Michael Richard Sandusky has stepped down as director of BioClinica ApS.
As of May 12, 2025, Thomas Patrick Stuckey has stepped down as director of BioClinica ApS.
As of May 12, 2025, Timothy Alan Cobb has stepped down as director of BioClinica ApS.
On May 12, 2025, BioClinica ApS entered liquidation.
As of October 29, 2024, Timothy Alan Cobb is registered as director of BioClinica ApS.
BioClinica ApS has published its annual report for 2023. Gross profit came to DKK -19,274, and the net result was DKK -24,530.
As of June 12, 2024, Michael Richard Sandusky is registered as director of BioClinica ApS.
As of April 22, 2024, Daniel Scott Braem has stepped down as adm. dir. of BioClinica ApS.
As of October 31, 2023, Thomas Patrick Stuckey is registered as director of BioClinica ApS.
BioClinica ApS has published its annual report for 2022. Gross profit came to DKK -22,036, and the net result was DKK -22,672.
As of April 27, 2023, Daniel Scott Braem is registered as adm. dir. of BioClinica ApS.
As of March 28, 2023, Michael John Bonello has stepped down as director of BioClinica ApS.
As of March 15, 2023, Maureen Waters Marchek has stepped down as director of BioClinica ApS.
BioClinica ApS has published its interim report for the period July 31, 2020 – December 31, 2021.
As of June 29, 2022, Michael John Bonello is registered as director of BioClinica ApS.
As of June 29, 2022, Christopher Orlando has stepped down as director of BioClinica ApS.
As of June 29, 2022, Charles R Bodner has stepped down as director of BioClinica ApS.
As of July 31, 2020, Christopher Orlando is registered as director of BioClinica ApS.
As of July 31, 2020, Charles R Bodner is registered as director of BioClinica ApS.
As of July 31, 2020, Maureen Waters Marchek is registered as director of BioClinica ApS.
BioClinica ApS was founded on July 31, 2020.
Companies in the same industry and area
CVR 45506983
CVR 44695065
CVR 40172076
CVR 44828596
CVR 46314964